Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis Strains
Molecules · 09.09.2023 · 28 (18) · 6535
DOI: 10.3390/molecules28186535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 09.09.2023. Verfasst von Gabriele Carullo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Quinazolinones, Cystic Fibrosis, Virulence Factors. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases.
Abstract (Originalsprache)
Pseudomonas aeruginosa (PA), one of the ESKAPE pathogens, is an opportunistic Gram-negative bacterium responsible for nosocomial infections in humans but also for infections in patients affected by AIDS, cancer, or cystic fibrosis (CF). Treatment of PA infections in CF patients is a global healthcare problem due to the ability of PA to gain antibiotic tolerance through biofilm formation. Anti-virulence compounds represent a promising approach as adjuvant therapy, which could reduce or eliminate the pathogenicity of PA without impacting its growth. Pyocyanin is one of the virulence factors whose production is modulated by the Pseudomonas quinolone signal (PQS) through its receptor PqsR. Different PqsR modulators have been synthesized over the years, highlighting this new powerful therapeutic strategy. Based on the promising structure of quinazolin-4(3H)-one, we developed compounds 7a–d, 8a,b, 9, 10, and 11a–f able to reduce biofilm formation and the production of virulence factors (pyocyanin and pyoverdine) at 50 µM in two PA strains responsible for CF acute and chronic infections. The developed compounds did not reduce the cell viability of IB3-1 bronchial CF cells, and computational studies confirmed the potential ability of novel compounds to act as potential Pqs system modulators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
- Department of Medical, Oral and Biotechnological Sciences, School of Medicine and Health Sciences "G. d'Annunzio" University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy.
- Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy.
ORCID-Profile: Gabriele Carullo, Giovanni Di Bonaventura, Sara Rossi, Simone Brogi, Stefania Butini, Sandra Gemma, Arianna Pompilio
Förderung
- NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
Zitieren
APA
Carullo, G., Di Bonaventura, G., Rossi, S., Lupetti, V., Tudino, V., Brogi, S., Butini, S., Campiani, G., Gemma, S., & Pompilio, A. (2023). Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis Strains. Molecules, 28(18), 6535. https://doi.org/10.3390/molecules28186535
Vancouver
Carullo G, Di Bonaventura G, Rossi S, Lupetti V, Tudino V, Brogi S, et al. Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis Strains. Molecules. 2023;28(18):6535. doi:10.3390/molecules28186535
BibTeX
@article{Carullo2023,
author = {Carullo, Gabriele and Di Bonaventura, Giovanni and Rossi, Sara and Lupetti, Veronica and Tudino, Valeria and Brogi, Simone and Butini, Stefania and Campiani, Giuseppe and Gemma, Sandra and Pompilio, Arianna},
title = {Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis Strains},
journal = {Molecules},
year = {2023},
volume = {28},
number = {18},
pages = {6535},
doi = {10.3390/molecules28186535}
}
EUVIMED